in an tight $8 trading range. 6/8 weeks away from UNC2 P2 proof of Concept Data. Any significant stock price weakness should be bought before UNC2 results.I will say this .... its more likely we get positive data and an NBIX run into double digits as we get into Q4. The stock is undervalued IMO but who am I. Biotech sector is not in favor with investors.
Just look at the $8 no volume trade fof the whole month of July